The drug cabozantinib is more effective than two similar drugs, as well as the current standard treatment, in extending the lives of patients with a rare and deadly type of kidney cancer, according to a new study. The cancer is called metastatic papillary kidney cancer. There are currently no effective treatments for it. A previous… read on > read on >



















